FIELD: medicine; rheumatology.
SUBSTANCE: invention can be used for treatment of steroid-dependant rheumatoid arthritis. For this purpose basic and anti-inflammatory therapy is performed including agents of calcium and native vitamin D. Additionally agent of active vitamin D - alpha-calcydol is prescribed. At that agent dose from minimum (0.5 mcg) to maximum (1.5 mcg), therapy duration and multiplicity are prescribed on the basis of dose and duration of prescribed corticosteroids in terms of prednisolone.
EFFECT: invention enables to increase remission period due to individual optimal selection of therapy.
4 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING RHEUMATOID ARTHRITIS | 2004 |
|
RU2268734C1 |
METHOD FOR TREATING RHEUMATIC ARTHRITIS | 1992 |
|
RU2038082C1 |
METHOD OF TREATING JUVENILE RHEUMATIC ARTHRITIS | 0 |
|
SU1553130A1 |
METHOD TO CHOOSE EFFERENT THERAPY AT RHEUMATOID ARTHRITIS | 1994 |
|
RU2089221C1 |
METHOD FOR TREATING RHEUMATOID ARTHRITIS | 2001 |
|
RU2199320C1 |
METHOD FOR PREVENTING OSTEOPOROSIS IN PATIENTS WITH CICD | 2005 |
|
RU2294747C1 |
METHOD FOR EVALUATING EFFICIENCY OF TREATMENT OF RHEUMATOID ARTHRITIS | 1994 |
|
RU2088930C1 |
METHOD OF CURING COMPLICATED RHEUMATOID ARTHRITIS | 1990 |
|
RU2016580C1 |
METHOD OF CORRECTION OF METABOLISM IN OSTEAL TISSUE | 1992 |
|
RU2029550C1 |
METHOD OF RHEUMATOID ARTHRITIS TREATMENT | 2010 |
|
RU2437666C1 |
Authors
Dates
2008-06-20—Published
2006-05-12—Filed